Overview
- 4 public-safe observations are available for this inspection.
- 2 structured CFR citations are represented.
- 2 investigators are tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
7 Dec 2021
21 CFR 211.186(b)(9)
Complete instructions, procedures, specifications et. al.
Cited by Marcellinus D Dordunoo, Daniel J Min
7 Dec 2021
21 CFR 211.186(b)(9)
Complete instructions, procedures, specifications et. al.
Cited by Marcellinus D Dordunoo, Daniel J Min
7 Dec 2021
21 CFR 211.84(d)(2)
Component identification test
Cited by Marcellinus D Dordunoo, Daniel J Min
7 Dec 2021
21 CFR 211.84(d)(2)
Component identification test
Cited by Marcellinus D Dordunoo, Daniel J Min
Inspected site
SLSigmaPharm Laboratories LLCBensalem, United States
Inspection team
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.186(b)(9) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.84(d)(2) | Cited across public-safe Form 483 observations | 2x |
Full 483 report
Get the verbatim text of all 4 observations
The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere